anonymous
Guest
anonymous
Guest
What’s up with all the psych job postings? Good/bad situation etc?
So there is no new product or new indication in psych division? Seems a bit odd they’d be expanding then?Yes, I am curious as well. Seems like for a drug that's been on the market for 7 years with little to no advantages over it's competitor, this could be a recipe for disaster. Usually this leads to smaller territories and way too many reps stepping all over each other plus more bickering as to who gets credit for scripts. I get the LTC and CMH thing, but the competitor already owns the HD neuro space and the Psych territories already seem pretty small which ultimately means worsened IC plan.
Maybe they are preparing for the massive headcount loss with everyone interviewing for these BMS/Karona positions.?So there is no new product or new indication in psych division? Seems a bit odd they’d be expanding then?
It’s Kurana and that’s not the case.Maybe they are preparing for the massive headcount loss with everyone interviewing for these BMS/Karona positions.?
Stop already with the added headcount. We have plenty of territory coverage and no one wants to be stepping all over each other. We already have inner fighting amongst colleagues going on over who should be getting credit for the business.What’s up with all the psych job postings? Good/bad situation etc?
Actually it's Karuna. And it no longer exists. Nobody is going to take a pay cut and go to BMS, especially since it Big PharmaIt’s Kurana and that’s not the case.
So r u saying this is not big pharm?Actually it's Karuna. And it no longer exists. Nobody is going to take a pay cut and go to BMS, especially since it Big Pharma
It’s happening like it or not.Stop already with the added headcount. We have plenty of territory coverage and no one wants to be stepping all over each other. We already have inner fighting amongst colleagues going on over who should be getting credit for the business.
This appears to be more about backfilling and adding headcount due to our competitor leveling the playing field with their new and easier once daily dosing. They also have 8 different dosage strengths compared to our 3.It’s happening like it or not.
really, this is quite comical.This appears to be more about backfilling and adding headcount due to our competitor leveling the playing field with their new and easier once daily dosing. They also have 8 different dosage strengths compared to our 3.
Yeh, our key writers are really laughing. I was told today that this is what one of my biggest writers has been waiting for.really, this is quite comical.
Somebody getting scared. Sounds like your doc is intimidating you. Step aside and leave. You won’t be missed and they’ll be a dozen better reps than you lined up to take your job over.Yeh, our key writers are really laughing. I was told today that this is what one of my biggest writers has been waiting for.
Ok Teva trollYeh, our key writers are really laughing. I was told today that this is what one of my biggest writers has been waiting for.
Dumb repMaybe the company is raising its headcount for a sale? The time to sell would be well timed since the CEO leaves in Oct.
Ok, well this dumb rep is about to depart all this crazy rationale of adding more headcount just so we can step all over each other even more. Ridiculous that we need so many people in a disease state that really isn't aggressively being treated.Dumb rep
Not a Teva Troll, but we sure have hired a lot of them. Quite frankly, most of them were underperformers or rejects and came here for a few extra bucks.Ok Teva troll
Still here Teva troll?Ok, well this dumb rep is about to depart all this crazy rationale of adding more headcount just so we can step all over each other even more. Ridiculous that we need so many people in a disease state that really isn't aggressively being treated.